ALB and cancer: Albumin alone has been proposed as a biomarker of cachexia (Goodrose-Flores et al. 2022), with a negative prognostic value in advanced cancer and an association with cancer-related symptoms (Goodrose-Flores et al. 2022, Stares et al. 2021).